olink
oligosaccharid
matur
form
herp
simplex
viru
type
hsvl
glycoprotein
character
found
account
larg
lower
electrophoret
mobil
form
rel
mobil
immatur
form
posttransl
modif
hsvl
glycoprotein
design
gb
gc
gd
ge
relat
tempor
discret
shift
electrophoret
mobil
signal
acquisit
olink
oligosaccharid
fatti
acid
acyl
princip
ge
could
detect
prior
shift
wherea
convers
highmannosetyp
nlink
oligosaccharid
complex
type
occur
coincid
shift
addit
olink
oligosaccharid
occur
cell
treat
ionophor
monensin
ricinresist
cell
line
defect
process
nlink
oligosaccharid
conclud
extens
olink
oligosaccharid
chain
hsvi
glycoprotein
probabl
also
attach
first
olink
sugar
occur
late
posttransl
modif
golgi
apparatu
acquir
herp
simplex
viru
glycoprotein
golgi
apparatu
david
c
johnson
patricia
g
spear
depart
microbiolog
univers
chicago
chicago
illinoi
olink
oligosaccharid
matur
form
herp
simplex
viru
type
hsvl
glycoprotein
character
found
account
larg
lower
electrophoret
mobil
form
rel
mobil
immatur
form
posttransl
modif
hsvl
glycoprotein
design
gb
gc
gd
ge
relat
tempor
discret
shift
electrophoret
mobil
signal
acquisit
olink
oligosaccharid
fatti
acid
acyl
princip
ge
could
detect
prior
shift
wherea
convers
highmannosetyp
nlink
oligosaccharid
complex
type
occur
coincid
shift
addit
olink
oligosaccharid
occur
cell
treat
ionophor
monensin
ricinresist
cell
line
defect
process
nlink
oligosaccharid
conclud
extens
olink
oligosaccharid
chain
hsvi
glycoprotein
probabl
also
attach
first
olink
sugar
occur
late
posttransl
modif
golgi
apparatu
consider
attent
focus
defin
intracellular
locat
function
signific
variou
step
synthesi
process
membranebound
secret
glycoprotein
site
synthesi
glycoprotein
membranebound
ribosom
rough
endoplasm
reticulum
highmannosetyp
oligosaccharid
transfer
en
bloc
dolichol
phosphat
donor
asparagin
residu
nascent
chain
struck
lennarz
small
hydrophob
leader
sequenc
remov
blobel
et
al
polypeptid
transport
unknown
mechan
perhap
involv
clathrinco
vesicl
rothman
et
al
golgi
apparatu
fatti
acid
molecul
may
attach
schmidt
schlesing
dunphi
et
al
highmannos
asparaginelink
nlink
oligosaccharid
process
complextyp
oligosaccharid
taba
kornfeld
bretz
et
al
bennett
oshaughnessi
roth
berger
golgi
apparatu
glycoprotein
move
cell
surfac
target
cellular
organel
lysosom
neufeld
ashwel
much
less
known
structur
assembl
attach
olink
oligosaccharid
glycoprotein
known
nlink
oligosaccharid
occurr
olink
oligosaccharid
first
recogn
glycoprotein
mucou
secret
carlson
subsequ
glycoprotein
fetuin
spiro
bhoyroo
human
chorion
gonadotropin
bahl
erythrocyt
glycophorin
thoma
winzler
found
contain
olink
nlink
oligosaccharid
olink
oligosaccharid
attach
serin
threonin
via
nacetylgalactosamin
galnac
residu
structur
oligosaccharid
chain
vari
disaccharid
compos
galnac
sialic
acid
larg
oligosaccharid
sugar
residu
contain
galnac
galactos
nacetylglucosamin
fucos
sialic
acid
sever
studi
address
question
stage
locat
olink
oligosaccharid
attach
glycoprotein
intracellular
transport
strou
conclud
galnac
could
ad
oglycosid
linkag
grow
polypeptid
rough
endoplasm
reticulum
wherea
other
kim
et
al
ko
raghupathi
hanov
et
al
found
enzym
capabl
mediat
reaction
enrich
smooth
endoplasm
reticulum
golgi
membran
rather
rough
endoplasm
reticulum
membran
cell
infect
herp
simplex
viru
provid
use
system
investig
process
discuss
previou
studi
shown
glycoprotein
specifi
herp
simplex
viru
type
hsvl
contain
olink
oligosaccharid
oloffson
et
al
well
nlink
oligosaccharid
pizer
et
al
serafinicessi
campadellifium
person
et
al
wensk
et
al
confirm
find
character
olink
oligosaccharid
shown
incorpor
one
hsvl
glycoprotein
also
shown
rel
larg
differ
electrophoret
mobil
matur
immatur
form
hsvl
glycoprotein
spear
bauck
spear
eisenberg
et
al
eberl
courtney
due
primarili
presenc
olink
oligosaccharid
chain
matur
form
use
discret
shift
electrophoret
mobil
occur
posttransl
process
glycoprotein
marker
acquisit
olink
oligosaccharid
investig
tempor
order
posttransl
modif
fatti
acid
acyl
process
nlink
oligosaccharid
occur
rel
shift
studi
carri
condit
design
allow
normal
glycoprotein
process
also
presenc
monensin
ionophor
known
caus
accumul
secret
membran
protein
virion
golgideriv
vacuol
tartakoff
vassal
uchida
et
al
johnson
schlesing
johnson
spear
ricinresist
cell
defect
process
nlink
oligosaccharid
result
indic
extens
olink
oligosaccharid
yield
chain
suffici
number
size
affect
electrophoret
mobil
glycoprotein
probabl
also
addit
first
amino
acidlink
galnac
residu
occur
golgi
apparatu
subsequ
addit
fatti
acid
coincid
process
highmannosetyp
nlink
oligosaccharid
complextyp
oligosaccharid
releas
hsvl
glycoprotein
mild
alkalin
borohydrid
hsvi
glycoprotein
label
cglucosamin
infect
cell
glucosamin
convert
galactosamin
sialic
acid
incorpor
oligosaccharid
eucaryot
cell
kornfeld
ginsberg
oloffson
et
al
clabel
hsvl
glycoprotein
gc
gd
isol
prepar
sdspolyacrylamid
gel
treat
naoh
nabha
hr
mild
alkalin
borohydrid
condit
shown
select
releas
olink
oligosaccharid
spiro
marshal
neuberg
mixtur
releas
oligosaccharid
glycoprotein
chromatograph
biorad
total
label
observ
peak
void
volum
v
presum
due
nlink
oligosaccharid
remain
attach
glycoprotein
label
materi
releas
gc
gd
includ
column
elut
princip
three
peak
peak
contain
materi
approxim
dalton
peak
ii
approxim
dalton
peak
ill
contain
materi
larg
stachyos
dalton
small
glucosamin
dalton
similar
distribut
label
observ
prepar
hsvi
gc
isol
radioimmunoprecipit
examin
result
shown
label
materi
includ
column
gc
chromatograph
directli
purif
treat
result
shown
oligosaccharid
releas
condit
isol
vesicular
stomat
viru
vsv
g
protein
figur
contain
nlink
oligosaccharid
moyer
et
al
two
kind
experi
carri
character
gc
oligosaccharid
releas
elimin
first
isol
glycoprotein
digest
exoglycosidas
prior
treatment
alkalin
borohydrid
elut
profil
oligosaccharid
releas
neuraminidasetr
gc
figur
markedli
differ
untreat
gc
figur
peak
ii
absent
new
peak
materi
appear
smaller
appar
molecular
weight
glycopeptid
ovalbumin
dalton
therefor
oligosaccharid
peak
ii
highli
sialat
treatment
desial
gc
bgalactosidas
produc
small
shift
elut
profil
oligosaccharid
releas
alkalin
borohydrid
result
shown
second
gc
isol
cell
label
cgalactos
instead
cglucosamin
subject
alkalin
borohydrid
treatment
elut
profil
shown
figur
f
indic
oligosaccharid
peak
ii
ill
contain
galactos
observ
preferenti
label
larger
molecular
weight
materi
peak
ill
consist
idea
peak
ill
compos
multipl
oligosaccharid
differ
molecular
weight
larger
molecular
weight
form
contain
rel
galactos
releas
oligosaccharid
hsvl
glycoprotein
result
decreas
electrophoret
mobil
glycoprotein
prepar
enzym
adnacetylgalactosamin
oligosaccharidas
galnac
oligosaccharidas
purifi
clostridium
perfringen
found
releas
olink
oligosaccharid
porcin
submaxillari
mucin
cleavag
serin
threonin
residu
galnac
huang
aminoff
pomato
aminoff
appropri
condit
enzym
releas
oligosaccharid
matur
form
hsvl
gc
releas
materi
elut
profil
similar
oligosaccharid
releas
alkalin
borohydrid
figur
distribut
label
three
peak
somewhat
differ
galnac
oligosaccharidas
digest
perhap
larger
oligosaccharid
resist
releas
enzym
suggest
enzym
less
activ
remov
sialat
oligosaccharid
desial
oligosaccharid
n
pomato
personn
commun
galnac
oligosaccharidas
releas
oligosaccharid
vsv
g
protein
condit
figur
addit
treatment
vsv
g
protein
enzym
affect
mobil
glycoprotein
sdspolyacrylamid
gel
might
observ
oligosaccharid
monosaccharid
remov
figur
hsvl
glycoprotein
label
pulsechas
experi
matur
immatur
form
glycoprotein
precipit
monoclon
antibodi
prior
treatment
galnac
oligosaccharidas
result
present
figur
illustr
phenomenon
report
previous
spear
bauck
spear
eisenberg
et
al
eberl
courtney
name
posttransl
process
hsvl
glycoprotein
accompani
discret
shift
electrophoret
mobil
lower
mobil
extract
prepar
immedi
min
puls
contain
fastermigr
immatur
form
glycoprotein
label
speci
wherea
extract
prepar
hr
chase
contain
princip
slowli
mi
grate
matur
form
form
observ
hr
chase
although
immatur
form
tend
abund
immatur
form
hsvl
glycoprotein
insensit
galnac
oligosaccharidas
figur
howev
mobil
matur
form
gb
gc
gd
ge
result
shown
ge
increas
treatment
galnac
oligosaccharidas
fact
mobil
enzymetr
matur
glycoprotein
resembl
close
respect
immatur
form
suggest
shift
mobil
occur
matur
glycoprotein
result
primarili
addit
extens
olink
oligosaccharid
chain
posttransl
rather
cotransl
modif
shift
electrophoret
mobil
glycoprotein
occur
min
hr
polypeptid
synthes
partial
glycosyl
note
use
galnac
oligosaccharidas
level
time
higher
use
studi
absenc
ovalbumin
produc
shift
mobil
vsv
g
protein
immatur
hsvl
glycoprotein
suggest
presenc
contamin
exoglycosid
endoglycosid
activ
vsv
g
protein
immatur
form
hsvl
glycoprotein
serv
intern
control
ensur
contamin
activ
dilut
suppress
effect
neuraminidas
electrophoret
mobil
hsvl
glycoprotein
test
possibl
addit
sialic
acid
residu
olink
oligosaccharid
princip
caus
decreas
electrophoret
mobil
associ
matur
hsvl
glycoprotein
treat
immunoprecipit
glycoprotein
label
pulsechas
experi
neuraminidas
condit
use
enzymat
digest
shown
separ
experi
remov
cnacetylmannosamin
label
incorpor
gc
gd
data
present
electrophoret
mobil
matur
form
gc
gd
increas
neuraminidas
treatment
extent
observ
treatment
galnac
oligosaccharidas
figur
electrophoret
mobil
immatur
form
affect
neuraminidas
similar
result
obtain
experi
carri
gb
ge
result
shown
except
difficult
compar
small
shift
mobil
gb
obtain
use
either
enzym
ge
howev
slight
increas
mobil
neuraminidas
treatment
found
gc
figur
note
neuraminidas
remov
sialic
acid
nlink
olink
oligosaccharid
shift
electrophoret
mobil
observ
overestim
effect
due
remov
sialic
acid
olink
oligosaccharid
hsvl
protein
label
min
smethionin
protein
immedi
extract
lane
p
label
chase
hr
lane
cl
hr
lane
extract
hsvi
glycoprotein
gb
gc
gd
immunoprecipit
monoclon
antibodi
elut
sd
pmercaptoethanol
dialyz
sd
vsv
protein
isol
hsvl
glycoprotein
mix
ovalbumin
mgml
final
concentr
either
treat
lane
treat
lane
galnac
oligosaccharidas
hr
c
prior
analysi
electrophoresi
hsvi
protein
label
min
smethionin
protein
immedi
extract
lane
p
label
chase
hr
lane
c
extract
hsvl
glycoprotein
gc
gd
immunoprecipit
monoclon
antibodi
staphylococcu
aureu
complex
wash
twice
sodium
acet
ph
mm
incub
enzym
lane
neuraminidas
uml
hr
lane
n
altern
complex
wash
twice
sodium
phosphat
ph
sd
mgml
ovalbumin
incub
galnac
oligosaccharidas
muml
hr
lane
matur
form
desial
retain
suffici
monensin
block
acquisit
olink
olink
oligosaccharid
remain
electrophooligosaccharid
retic
differenti
immatur
form
johnson
spear
other
wensk
consist
find
desial
oligosacet
al
shown
monensin
prevent
charid
releas
alkalin
borohydrid
treatment
posttransl
process
event
result
deof
consider
size
figur
creas
electrophoret
mobil
hsvl
glycoprotein
determin
whether
abnorm
form
glycoprotein
accumul
presenc
monensin
contain
olink
oligosaccharid
carri
two
experi
first
gd
isol
monensintr
infect
ceil
treat
mild
alkalin
borohydrid
reaction
mixtur
chromatograph
result
shown
figur
demonstr
oligosaccharid
monosaccharid
releas
condit
second
experi
determin
whether
galnac
oligosaccharidas
alter
elec
trophoret
mobil
gd
gc
isol
monensintr
cell
immunoprecipit
data
figur
illustr
previou
find
monensin
block
modif
glycoprotein
respons
decreas
electrophoret
mobil
show
also
glycoprotein
accumul
monensintr
cell
resist
enzym
taken
togeth
find
provid
evid
monensin
block
attach
olink
oligosaccharid
herp
simplex
viru
glycoprotein
oligosaccharid
larg
respons
shift
electrophoret
mobil
normal
observ
moreov
posttransl
modif
must
occur
late
intracellular
transport
glycoprotein
cell
surfac
stage
pass
golgi
apparatu
hsvi
protein
label
methionin
untreat
lane
untreat
monensintr
lane
monensin
cell
min
protein
immedi
extract
lane
p
label
chase
hr
lane
c
extract
glycoprotein
gc
gd
isol
immunoprecipit
monoclon
antibodi
treat
lane
treat
lane
galnac
oligosaccharidas
subject
electrophoresi
sdspolyacrylamid
gel
matur
form
glycoprotein
design
gc
gd
immatur
form
design
pgc
pgd
label
methionin
describ
legend
figur
extract
immedi
puls
lane
p
chase
period
hr
lane
cl
hr
lane
follow
immunoprecipit
monoclon
antibodi
isol
glycoprotein
treat
endo
h
lane
treat
lane
electrophores
sdspolyacrylamid
gel
coprotein
gb
gd
gc
ge
endo
h
result
mark
increas
electrophoret
mobil
sdspolyacrylamid
gel
figur
glycoprotein
process
form
slower
electrophoreti
mobil
hr
chase
period
becam
resist
endo
h
report
other
serafinicessi
campadellifium
person
et
al
wensk
et
al
found
wensk
et
al
gb
remain
partial
sensit
endo
h
therefor
convers
immatur
form
hsvl
glycoprotein
matur
form
parallel
convers
endo
hsensit
form
endo
hresist
form
appear
form
glycoprotein
olink
oligosaccharid
also
fulli
process
nlink
oligosaccharid
coval
attach
fatti
acid
molecul
viral
glycoprotein
describ
occur
pass
golgi
apparatu
schmidt
et
al
schmidt
schlesing
dunphi
et
al
four
hsvl
glycoprotein
studi
ge
igg
fc
receptor
bauck
spear
found
incorpor
signific
quantiti
label
figur
cell
pulselabel
min
immatur
form
ge
preferenti
label
therefor
attach
fatti
acid
thought
occur
earli
transport
viral
glycoprotein
golgi
apparatu
appear
preced
attach
olink
oligosaccharid
ricinresist
cell
line
isol
gottlieb
kornfeld
feld
infect
cell
parent
cell
line
hsvl
compar
respect
process
viral
glycoprotein
immatur
form
gb
gd
convert
slowli
migrat
matur
form
gb
gd
cell
figur
observ
cell
howev
matur
form
gb
gd
appear
chase
period
cell
glycoprotein
detect
cell
sensit
galnac
oligosaccharidas
result
shown
result
consist
idea
hsvl
p
c
slep
figur
attach
fatti
acid
hsvi
ge
hsvi
infect
cell
label
hpalmit
lane
palm
min
hr
extract
buffer
parallel
monolay
label
min
smethionin
lane
met
protein
immedi
extract
lane
p
label
chase
hr
lane
extract
precipit
monoclon
antibodi
electrophoresi
sdspolyacrylamid
gel
approxim
time
extract
cell
label
min
hoalmit
reauir
visual
tein
glycosyl
serin
threonin
residu
lectinresist
cell
line
result
confirm
previou
report
oloffson
et
al
presenc
olink
oligosaccharid
hsvl
glycoprotein
demonstr
also
olink
oligosaccharid
larg
respons
larg
differ
electrophoret
mobil
matur
immatur
form
glycoprotein
immatur
form
contain
olink
carbohydr
number
size
chain
must
small
affect
electrophoret
mobil
glycoprotein
linkag
must
resist
galnac
oligosaccharidas
result
obtain
analysi
gd
made
monensintr
cell
also
suggest
addit
galnac
serin
threonin
residu
polypeptid
normal
cotransl
earli
posttransl
event
unless
monensin
block
pregolgi
modif
unless
insuffici
radiolabel
incorpor
gd
permit
detect
small
monosaccharid
oligosaccharid
releas
alkalin
borohydrid
effect
neuraminidas
treatment
electrophoret
mobil
matur
glycoprotein
indic
sialat
olink
oligosaccharid
account
fulli
processinglink
shift
electrophoret
mobil
therefor
carbohydr
moieti
sialic
acid
galactos
nacetylglucosamin
must
account
partial
decreas
electrophoret
mobil
larger
appar
size
associ
presenc
olink
chain
present
evid
step
synthesi
olink
oligosaccharid
result
decreas
pge
band
rel
ge
label
hr
golgi
apparatu
first
shift
electrophoreti
mobil
occur
addit
fatti
acid
ge
coincid
time
process
nlink
oligosaccharid
highmannos
complextyp
oligosaccharid
process
shown
occur
golgi
apparatu
schmidt
schlesing
dunphi
et
al
taba
kornfeld
bretz
et
al
second
ionophor
monensin
interfer
golgi
function
tartakoff
vassal
block
process
nlink
oligosaccharid
hsvl
glycoprotein
wensk
et
al
addit
olink
oligosaccharid
conclus
intracellular
site
addit
olink
oligosaccharid
agreement
find
transferas
catalyz
attach
galnac
serin
andor
threonin
residu
rat
intestin
mucosa
kim
et
al
brain
ko
raghupathi
hen
oviduct
hanov
et
al
local
smooth
membran
contrast
strou
report
galnac
attach
nascent
epitheli
polypeptid
polysom
data
argu
attach
olink
oligosaccharid
nascent
hsvl
glycoprotein
although
possibl
small
amount
galnac
attach
cotransl
modif
escap
detect
find
olink
oligosaccharid
ad
hsvl
glycoprotein
cell
suggest
either
enzym
necessari
addit
defect
cell
therefor
cellular
genet
origin
attach
olink
oligosaccharid
conting
upon
process
nlink
oligosaccharid
cell
fail
attach
termin
sugar
nlink
oligosaccharid
gottlieb
kornfeld
process
known
occur
gotgi
apparatu
taba
kornfeld
bretz
et
al
roth
berger
remain
determin
whether
enzym
may
particip
addit
monosaccharid
nlink
olink
oligosaccharid
chain
experi
carri
vitro
shown
howev
enzym
prepar
capabl
ad
sugar
olink
oligosaccharid
may
abl
attach
sugar
nlink
oligosaccharid
review
schachter
roseman
campadellifium
et
al
recent
report
convers
highmannosetyp
nlink
oligosaccharid
hsvl
glycoprotein
complextyp
oligosaccharid
block
ricinresist
bhk
cell
line
infecti
virion
contain
immatur
glycoprotein
produc
nonetheless
whether
olink
oligosaccharid
attach
mutant
bhk
cell
line
discuss
author
report
howev
absenc
shift
electrophoret
mobil
shown
signal
addit
olink
oligosaccharid
investig
infect
virion
produc
mutant
cell
although
mous
l
cell
permiss
express
herp
simplex
viru
gene
semipermiss
product
infecti
viru
olink
oligosaccharid
constitut
major
fraction
label
carbohydr
hsvl
glycoprotein
consist
princip
three
size
fraction
largest
oligosaccharid
may
compar
size
composit
bloodgroup
substanc
describ
feizi
et
al
howev
larg
fraction
glucosamin
galactos
label
releas
mild
alkalin
borohydrid
hsvl
glycoprotein
chromatograph
smaller
molecular
weight
oligosaccharid
similar
disaccharid
trisaccharid
tetrasaccharid
observ
submaxillari
mucin
carlson
aminoff
et
al
fetuin
spiro
bhoyroo
human
iga
baenzig
kornfeld
certain
tumorcel
glycoprotein
bhavanandran
davidson
differ
electrophoret
mobil
matur
immatur
form
glycoprotein
suggest
larg
amount
olink
oligosaccharid
ad
speci
gc
exampl
although
exact
number
oligosaccharid
chain
estim
differ
interest
label
inorgan
sulfat
incorpor
ge
hope
et
al
sinc
olink
oligosaccharid
certain
submaxillari
gland
mucin
found
contain
sulfat
sugar
lombart
winzler
list
possibl
function
olink
oligosaccharid
would
includ
previous
propos
nlink
oligosaccharid
alter
initi
fold
final
conform
polypeptid
gibson
et
al
target
glycoprotein
specif
intracellular
organel
cell
surfac
neufeld
ashwel
protect
glycoprotein
proteolyt
degrad
schwartz
et
al
influenc
bind
properti
glycoprotein
probabl
rule
effect
olink
oligosaccharid
initi
fold
glycoprotein
seem
ad
rel
late
posttransl
modif
addit
function
hsvl
glycoprotein
essenti
virion
infect
cell
cultur
depend
presenc
olink
oligosaccharid
conclus
emerg
result
present
coupl
previou
find
johnson
spear
infecti
virion
produc
presenc
monensin
virion
accumul
intracytoplasm
vacuol
contain
immatur
glycoprotein
result
studi
suggest
virion
envelop
acquir
inner
nuclear
membran
initi
contain
immatur
glycoprotein
process
matur
form
virion
transport
golgi
apparatu
seem
unlik
olink
oligosaccharid
play
role
target
hsvl
glycoprotein
nuclear
membran
could
conceiv
play
role
transport
viral
glycoprotein
virion
cell
surfac
also
addit
oligosaccharid
serin
threonin
residu
cellular
viral
glycoprotein
alreadi
glycosyl
asparagin
residu
may
lead
increas
hydrat
cell
virion
surfac
increas
protect
proteolyt
degrad
olink
oligosaccharid
also
report
glycoprotein
specifi
vaccinia
viru
shida
dale
coronaviru
nieman
klenk
virus
share
common
hsvi
properti
acquir
envelop
intern
cellular
membran
rather
plasma
membran
immedi
contain
tenfold
excess
unlabel
methionin
ad
other
hr
hr
cell
wash
twice
pb
scrape
pb
contain
sodium
deoxychol
doc
ovalbumin
mgml
extract
buffer
glycoprotein
immunoprecipit
sd
mm
trishci
ph
glycoprotein
purifi
sdspolyacrylamid
gel
electrophoresi
cell
treat
gm
monensin
mm
stock
absolut
ethanol
hr
infect
hsvl
johnson
spear
purifi
prepar
electrophoresi
mm
thick
polyacrylamid
gel
crosslink
n
ndiallyltartardiamid
datd
hein
et
al
sd
extract
cglucosamineor
cgalactoselabel
cell
sonic
boil
min
electrophores
hr
per
gel
gel
immedi
dri
subject
autoradiographi
autoradiograph
use
detect
label
glycoprotein
label
glycoprotein
band
excis
dri
gel
hydrat
trisglycin
sd
glycerol
mg
ml
ovalbumin
mgml
cytochrom
c
electrophores
dialysi
tube
stephen
isol
glycoprotein
dialyz
sd
lyophil
altern
hsvl
glycoprotein
isol
immunoprecipit
monoclon
antibodi
specif
gb
specif
gc
specif
gd
specif
ge
previous
describ
johnson
spear
dialyz
sd
treatment
enzym
elut
sd
mm
trishci
ph
glycerol
electrophoresi
polyacrylamid
gel
crosslink
datd
hein
et
al
analyt
gel
impregn
banner
laskey
dri
place
contact
cronex
medic
xray
film
treatment
glycoprotein
gel
filtrat
oligosaccharid
viral
glycoprotein
incub
naoh
hr
describ
carlson
high
concentr
found
necessari
prevent
destruct
galnac
link
serin
threonin
carlson
et
al
excess
borohydrid
destroy
addit
hci
ph
mixtur
chromatograph
column
x
cm
biorad
mesh
elut
nhihcoj
sd
fraction
collect
aliquot
dri
glass
filter
count
column
calibr
blue
dextran
v
glycopeptid
deriv
pronas
digest
fetuin
dalton
spiro
ovalbumin
dalton
spiro
stachyos
lactos
nacetylglucosamin
v
digest
galnac
oligosaccharidas
bethesda
research
laboratori
perform
enzym
concentr
mu
ml
isol
viral
glycoprotein
presenc
ovalbumin
mg
ml
sd
ph
hr
digest
immedi
stop
addit
sd
boil
min
load
onto
column
subject
electrophoresi
isol
hsvl
glycoprotein
treat
neuraminidas
type
x
sigma
uml
mm
sodium
acet
ph
mm
caci
hr
glycoprotein
treat
type
vii
sigma
uml
mm
ph
hr
endo
h
mile
laboratori
use
muml
sodium
citrat
buffer
ph
sd
